LONDON: Sanofi Pasteur, Sanofi's vaccines unit, said on Tuesday that its dengue vaccine, Dengvaxia, had received market approval in eleven countries.
To date the vaccine has been approved in Mexico, the Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore, the statement said.
Dengue fever is a mosquito-borne disease caused by four virus serotypes (1 to 4) as categorized by the World Health Organisation. Overall, the disease is seen as a threat to about half of the world's population. Some 400 million people are believed to be infected annually.
Social anxiety tends to affect people's daily life interactions
Prostate cancer constitutes 15% of all male cancers and with an increase of 85%, it will cause 700,000 deaths annually
Apple cider vinegar can possibly help people lose weight, claims study
Mental health can be improved by consuming nutritional diet
Autism is common disorder affecting many children around world
Hazardous chemical compounds in hand sanitizers can damage people's brains, as per research